Overview the roles of lncRNAs in regulating PD-L1 expression
LncRNA | Cancer types | Regulated targets | Mechanisms | Reference |
---|---|---|---|---|
MALAT1 | DLBCL | miR-195 | MALAT1 sponges miR-195 to promote PD-L1 expression | 7 |
EMX2OS | OC | miR-654 | EMX2OS interacts with miR-654 to increase PD-L1 expression | 7 |
MIR17HG | CRC | miR-375 | MIR17HG induces PD-L1 expression via sponging miR-375 | 7 |
GATA3-AS1 | BC | miR-676-3p/COPS5 | GATA3-AS1 increases PD-L1 expression by regulating the miR-676-3p/COPS5 pathway | 7 |
KCNQ1OT1 | PC | miR-15a | KCNQ1OT1 activates PD-L1 expression through binding to and inactivating miR-15a | 7 |
MALAT1 | LAD | miR-200a-3p | MALAT1 increases PD-L1 expression by sponging miR-200a-3p | 7 |
FGD5-AS1 | LAD | miR-142 | LncRNA FGD5-AS1 acts as a sponge of miR-142 to regulate PD-L1 expression | 7 |
LINC00473 | PC | miR-195-5p | LINC00473 enhances PD-L1 expression by binding to miR-195-5p | 7 |
KCNQ1OT1 | HCC | miR-506 | KCNQ1OT1 interacts with miR-506 to promote PD-L1 expression | 7 |
PCED1B-AS1 | HCC | miR-194-5p | PCED1B-AS1 enhances PD-L1 expression through binding to miR-194-5p | 7 |
Lnc-OC1 | EC | miR-34a | Lnc-OC1 enhances PD-L1 expression by sponging miR-34a | 7 |
MEG3 | EC | miR-216a | MEG3 upregulates PD-L1 expression by targeting miR-216a | 7 |
SNHG15 | GC | miR-141 | SNHG15 increases PD-L1 expression by targeting miR-141 | 7 |
HIF1A-AS2 | GC | miR-429 | HIF1A-AS2 contributes PD-L1 expression through binding to miR-429 | 7 |
NUTM2A-AS1 | GC | miR-376a | NUTM2A-AS1 enhances PD-L1 expression by sponging miR-376a | 7 |
CASC11 | HCC | NF-κB | CASC11 activates NF-κB to further increase PD-L1 expression | 8 |
XIST | HCC | miR-194-5p/miR-155-5p | XIST promotes PD-L1 expression via targeting miR-194-5p and miR-155-5p | 8 |
PMSB8-AS1 | PC | STAT1 | PMSB8-AS1 increases STAT1 expression to further promote PD-L1 expression | 8 |
NKX2-1-AS1 | LAD | NKX2-1 | NKX2-1-AS1 inhibits PD-L1 expression through modulating NKX2-1 expression | 8 |
ZFPM2-AS1 | LAD | JAK-STAT/AKT | ZFPM2-AS1 increases PD-L1 expression via regulating JAK-STAT/AKT pathways | 8 |
LncAMPC | PC | miR-637 | LncAMPC acts as a sponge of miR-637 to regulate PD-L1 expression | 8 |
INCR1 | Thy | HNRNPH1 | Binding between INCR1 and HNRNPH1 suppresses PD-L1 expression | 8 |
LncMX1-215 | HNSCC | GCN5 | LncMX1-215 negatively regulates PD-L1 expression by suppressing H3K27 acetylation via binding to GCN5 | 8 |
AFAP1-AS1 | NPC | miR-519 | AFAP1-AS1 upregulates PD-L1 expression via directly targeting miR-519 | 8 |
SNHG20 | ESCC | ATM/JAK | SNHG20 regulates PD-L1 expression through modulation of the ATM/JAK pathway | 8 |
UCA1 | ATC | miR-148a | UCA1 interacts with miR-148a to promote PD-L1 expression | 8 |
DLBCL, diffuse large B cell lymphoma; OC, ovarian cancer; EC, endometrial cancer; GC, gastric cancer; HCC, hepatocellular carcinoma; PC, pancreatic cancer; LAD, lung adenocarcinoma; BC, breast cancer; Thy, thymoma; HNSCC, head and neck squamous cell carcinoma; NPC, nasopharyngeal carcinoma; ESCC, esophageal squamous cell carcinoma; ATC, anaplastic thyroid carcinoma; CRC, colorectal cancer.